Please check your internet connection and try again.
# Linagliptin
## Overview
Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that increases incretin hormone concentrations, stimulating glucose-dependent insulin release and decreasing glucagon levels. It is unique among DPP-4 inhibitors for its primary biliary excretion rather than renal.
## Primary Indications
Type 2 diabetes mellitus (T2DM) as an adjunct to diet and exercise to improve glycemic control.
## Adult Dosing
Standard dose: 5 mg orally once daily.
Maximum dose: 5 mg daily.
## Pediatric Dosing
Safety and efficacy have not been established in patients younger than 18 years. Use is generally not recommended in pediatric populations.
## Dose Adjustments
* **Renal Impairment:** No dose adjustment required.
* **Hepatic Impairment:** No dose adjustment required.
* **Geriatric:** No dose adjustment required.
## Contraindications
* Hypersensitivity to linagliptin (anaphylaxis, angioedema, exfoliative skin conditions).
* History of pancreatitis (use with caution).
* Not for treatment of Type 1 diabetes or diabetic ketoacidosis.
## Adverse Effects
* **Common:** Nasopharyngitis, hypoglycemia (when used with insulin or secretagogues).
* **Serious:** Acute pancreatitis, severe arthralgia, bullous pemphigoid, hypersensitivity reactions.
## Key Drug Interactions
* **Strong CYP3A4/P-gp Inducers (e.g., Rifampin):** May decrease linagliptin efficacy. Avoid co-administration.
* **Insulin/Insulin Secretagogues (e.g., Sulfonylureas):** Increased risk of hypoglycemia; consider dose reduction of the secretagogue.
## Monitoring
* **HbA1c:** Monitor every 3–6 months.
* **Pancreatitis:** Monitor for signs of severe, persistent abdominal pain.
* **Skin:** Monitor for blistering or erosions suggestive of bullous pemphigoid.
## Clinical Pearls
* **Renal Sparing:** Linagliptin is the only DPP-4 inhibitor that does not require renal dose adjustments, making it a favorable choice in patients with chronic kidney disease.
* **Administration:** It can be taken with or without food.
* **Weight Neutral:** Generally considered weight-neutral compared to other agents like GLP-1 receptor agonists or insulin.
* **Missing Doses:** If a dose is missed, take it as soon as remembered, but do not double the dose.
***
*Disclaimer: This information is for educational purposes and does not substitute for professional medical judgment. Always verify current prescribing information, institutional protocols, and specific clinical guidelines before prescribing or administering medication.*
